Literature DB >> 32112533

Defining trauma-induced coagulopathy with respect to future implications for patient management: Communication from the SSC of the ISTH.

Hunter B Moore1, Satoshi Gando2,3, Toshiaki Iba4, Paul Y Kim5,6, Calvin H Yeh7, Karim Brohi8,9, Beverley J Hunt10, Jerrold H Levy11, Dominik F Draxler12, Simon Stanworth13,14,15, Klaus Görlinger16,17, Matthew D Neal18, Martin A Schreiber19, Christopher D Barrett20,21, Robert L Medcalf12, Ernest E Moore22, Nicola J Mutch23, Jecko Thachil24, Tetsumei Urano25, Scott Thomas26, Ecaterina Scărlătescu27, Mark Walsh26,28,29.   

Abstract

Entities:  

Mesh:

Year:  2020        PMID: 32112533     DOI: 10.1111/jth.14690

Source DB:  PubMed          Journal:  J Thromb Haemost        ISSN: 1538-7836            Impact factor:   5.824


× No keyword cloud information.
  15 in total

1.  Proteomics of Coagulopathy Following Injury Reveals Limitations of Using Laboratory Assessment to Define Trauma-Induced Coagulopathy to Predict Massive Transfusion.

Authors:  Hunter B Moore; Matthew D Neal; Marnie Bertolet; Brian A Joughin; Michael B Yaffe; Christopher D Barrett; Molly A Bird; Russell P Tracy; Ernest E Moore; Jason L Sperry; Brian S Zuckerbraun; Myung S Park; Mitchell J Cohen; Stephen R Wisniewski; James H Morrissey
Journal:  Ann Surg Open       Date:  2022-05-25

2.  Remote ischemic preconditioning improves tissue oxygenation in a porcine model of controlled hemorrhage without fluid resuscitation.

Authors:  Gal Yaniv; Arik Eisenkraft; Lilach Gavish; Linn Wagnert-Avraham; Dean Nachman; Jacob Megreli; Gil Shimon; Daniel Rimbrot; Ben Simon; Asaf Berman; Matan Cohen; David Kushnir; Ruth Shaylor; Baruch Batzofin; Shimon Firman; Amir Shlaifer; Michael Hartal; Yuval Heled; Elon Glassberg; Yitshak Kreiss; S David Gertz
Journal:  Sci Rep       Date:  2021-05-24       Impact factor: 4.379

3.  Euglobulin clot lysis time reveals a high frequency of fibrinolytic activation in trauma.

Authors:  Anton Ilich; Vaibhav Kumar; Michael J Ferrara; Michael W Henderson; Denis F Noubouossie; Donald H Jenkins; Rosemary A Kozar; Myung S Park; Nigel S Key
Journal:  Thromb Res       Date:  2021-05-31       Impact factor: 10.407

Review 4.  Trauma-induced coagulopathy.

Authors:  Ernest E Moore; Hunter B Moore; Lucy Z Kornblith; Matthew D Neal; Maureane Hoffman; Nicola J Mutch; Herbert Schöchl; Beverley J Hunt; Angela Sauaia
Journal:  Nat Rev Dis Primers       Date:  2021-04-29       Impact factor: 65.038

5.  Whole Blood Thrombin Generation in Severely Injured Patients Requiring Massive Transfusion.

Authors:  Julia R Coleman; Ernest E Moore; Jason M Samuels; Mitchell J Cohen; Christopher C Silliman; Arsen Ghasabyan; James Chandler; Saulius Butenas
Journal:  J Am Coll Surg       Date:  2021-02-04       Impact factor: 6.532

Review 6.  Fibrinolysis Shutdown in COVID-19: Clinical Manifestations, Molecular Mechanisms, and Therapeutic Implications.

Authors:  Jonathan P Meizoso; Hunter B Moore; Ernest E Moore
Journal:  J Am Coll Surg       Date:  2021-03-22       Impact factor: 6.113

7.  ADAMTS13 activity decreases in the early phase of trauma associated with coagulopathy and systemic inflammation: a prospective observational study.

Authors:  Hironori Matsumoto; Jun Takeba; Kensuke Umakoshi; Satoshi Kikuchi; Muneaki Ohshita; Suguru Annen; Naoki Moriyama; Yuki Nakabayashi; Norio Sato; Mayuki Aibiki
Journal:  Thromb J       Date:  2021-03-12

8.  Chinese expert consensus on diagnosis and treatment of trauma-induced hypercoagulopathy.

Authors:  Jing-Chun Song; Li-Kun Yang; Wei Zhao; Feng Zhu; Gang Wang; Yao-Peng Chen; Wei-Qin Li
Journal:  Mil Med Res       Date:  2021-04-12

9.  Emergence of institutional antithrombotic protocols for coronavirus 2019.

Authors:  Kevin P Cohoon; Guillaume Mahé; Alfonso J Tafur; Alex C Spyropoulos
Journal:  Res Pract Thromb Haemost       Date:  2020-06-12

10.  Initial clinical experience with the Quantra QStat System in adult trauma patients.

Authors:  Edward A Michelson; Michael W Cripps; Bradford Ray; Deborah A Winegar; Francesco Viola
Journal:  Trauma Surg Acute Care Open       Date:  2020-11-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.